Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase‐4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients-Reference-Cited by-同舟云学术

Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase‐4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients

Author:

Yang Chen‐Yi¹,Lin Wei‐Ann²,Su Pei‐Fang²,Li Lun‐Jie¹,Yang Chun‐Ting¹,Ou Huang‐Tz¹³⁴,Kuo Shihchen⁵⁶

Affiliation:

1. Institute of Clinical Pharmacy and Pharmaceutical Sciences College of Medicine National Cheng Kung University Tainan Taiwan

2. Department of Statistics National Cheng Kung University Tainan Taiwan

3. Department of Pharmacy College of Medicine National Cheng Kung University Tainan Taiwan

4. Department of Pharmacy National Cheng Kung University Hospital Tainan Taiwan

5. Division of Metabolism, Endocrinology, and Diabetes Department of Internal Medicine University of Michigan Ann Arbor Michigan USA

6. Michigan Center for Diabetes Translational Research University of Michigan Ann Arbor Michigan USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Ministry of Science and Technology

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference41 articles.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献